372 related articles for article (PubMed ID: 16651889)
1. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
2. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
3. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
5. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
[TBL] [Abstract][Full Text] [Related]
7. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
8. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Jellinger KA; Attems J
Acta Neuropathol; 2006 Sep; 112(3):253-60. PubMed ID: 16804711
[TBL] [Abstract][Full Text] [Related]
9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):131-5. PubMed ID: 15530662
[TBL] [Abstract][Full Text] [Related]
12. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
14. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.
Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M
J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
[TBL] [Abstract][Full Text] [Related]
16. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
[TBL] [Abstract][Full Text] [Related]
17. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.
Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Namba M; Hayashi Y; Nishinaka T; Namba R; Nakashima H; Uéda K; Checler F; Kuroda S
Acta Neuropathol; 2003 Oct; 106(4):348-56. PubMed ID: 12883830
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
[TBL] [Abstract][Full Text] [Related]
19. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
